GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID ▲ | UniProt ID | Title | Descriptor |
---|---|---|---|
8DLP | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 | |
8DLP | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 | |
8DLQ | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
8DLQ | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
8DLR | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4-8 (focused refinement of NTD and 4-8) | |
8DLR | 8DLR | Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4-8 (focused refinement of NTD and 4-8) | |
8DLS | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4A8 (focused refinement of NTD and 4A8) | |
8DLS | 8DLS | Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4A8 (focused refinement of NTD and 4A8) | |
8DLT | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein | |
8DLU | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 | |
8DLU | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 | |
8DLV | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
8DLV | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
8DLW | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with Fab S2M11 | |
8DLW | 8DLW | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with Fab S2M11 | |
8DLX | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 | |
8DLX | 8DLX | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 | |
8DLY | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6) | |
8DLY | 8DLY | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6) | |
8DLZ | P0DTC2 | Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 | |
8DLZ | 8DLZ | Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 | |
8DM0 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6) | |
8DM0 | 8DM0 | Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6) | |
8DM1 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein | |
8DM2 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein (focused refinement of NTD) | |
8DM3 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8 | |
8DM3 | 8DM3 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8 | |
8DM4 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8 (focused refinement of NTD and 4A8) | |
8DM4 | 8DM4 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8 (focused refinement of NTD and 4A8) | |
8DM5 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 | |
8DM5 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 | |
8DM6 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
8DM6 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
8DM7 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2 | |
8DM7 | Q8R0I0 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2 | |
8DM8 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2 (focused refinement of RBD and ACE2) | |
8DM8 | Q8R0I0 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2 (focused refinement of RBD and ACE2) | |
8DM9 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2 | |
8DM9 | Q8R0I0 | Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2 | |
8DMA | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2 (focused refinement of RBD and ACE2) | |
8DMA | Q8R0I0 | Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2 (focused refinement of RBD and ACE2) | |
8DMH | P09991 | Lymphocytic choriomeningitis virus glycoprotein in complex with neutralizing antibody M28 | |
8DMH | 8DMH | Lymphocytic choriomeningitis virus glycoprotein in complex with neutralizing antibody M28 | |
8DMH | Q9HIA7 | Lymphocytic choriomeningitis virus glycoprotein in complex with neutralizing antibody M28 | |
8DMI | P09991 | Lymphocytic choriomeningitis virus glycoprotein | |
8DMI | Q9HIA7 | Lymphocytic choriomeningitis virus glycoprotein | |
8DMK | P19137 | Cryo-EM reveals the molecular basis of laminin polymerization and LN-lamininopathies | |
8DMK | P07942 | Cryo-EM reveals the molecular basis of laminin polymerization and LN-lamininopathies | |
8DMK | P11047 | Cryo-EM reveals the molecular basis of laminin polymerization and LN-lamininopathies | |
8DN2 | P23415 | Cryo-EM structure of human Glycine Receptor alpha1-beta heteromer, glycine-bound state 2(expanded open) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024